Related references
Note: Only part of the references are listed.Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
Aharon Kessel et al.
AUTOIMMUNITY REVIEWS (2012)
Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
Raquel Planas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
The evidence for a role of B cells in multiple sclerosis
G. Disanto et al.
NEUROLOGY (2012)
Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab-A Flow Cytometric Study on Patients with Multiple Sclerosis
Andrea Harrer et al.
PLOS ONE (2012)
Effect of Natalizumab on Circulating CD4+ T-Cells in Multiple Sclerosis
Lars Bornsen et al.
PLOS ONE (2012)
B cells undergo unique compartmentalized redistribution in multiple sclerosis
Juergen Haas et al.
JOURNAL OF AUTOIMMUNITY (2011)
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
Mario Skarica et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission
Stephanie Knippenberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
J. M. Fletcher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Role of the innate immune system in the pathogenesis of multiple sclerosis
Roopali Gandhi et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
J. Mellergard et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
M. Khademi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
The significance of OX40 and OX40L to T-cell biology and immune disease
Michael Croft et al.
IMMUNOLOGICAL REVIEWS (2009)
Systemic Reduction of Functionally Suppressive CD4dimCD25highFoxp3+ Tregs in Human Second Trimester Pregnancy Is Induced by Progesterone and 17β-Estradiol
Jenny Mjosberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells
P. Kivisakk et al.
NEUROLOGY (2009)
The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans
Fabian Zohren et al.
BLOOD (2008)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
M. Krumbholz et al.
NEUROLOGY (2008)
Effects of Natalizumab Treatment on Foxp3+T Regulatory Cells
Max-Philipp Stenner et al.
PLOS ONE (2008)
NK cells at the interface between innate and adaptive immunity
A. Moretta et al.
CELL DEATH AND DIFFERENTIATION (2008)
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
Martin Duddy et al.
JOURNAL OF IMMUNOLOGY (2007)
Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis
Olaf Stuve et al.
ARCHIVES OF NEUROLOGY (2006)
Immune surveillance in multiple sclerosis patients treated with natalizumab
O Stüve et al.
ANNALS OF NEUROLOGY (2006)
Natalizumab effects on immune cell responses in multiple sclerosis
M Niino et al.
ANNALS OF NEUROLOGY (2006)
Phenotypic and functional characterization of human CD25+ B cells
M Brisslert et al.
IMMUNOLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Anti-α4 integrin therapy for multiple sclerosis -: Mechanisms and rationale
GPA Rice et al.
NEUROLOGY (2005)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses
M Mittelbrunn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus
A Svahn et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
JJ Campbell et al.
JOURNAL OF IMMUNOLOGY (2001)
The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient-based outcome measure
J Hobart et al.
BRAIN (2001)
Share Paper
